Uncategorized
Olopatadine 0.77% may reduce ocular itching faster, longer to treat allergic conjunctivitis
Once-daily olopatadine hydrochloride ophthalmic solution 0.77% may perform better than olopatadine 0.1% or 0.2%, with the added benefits of a fast-acting response and reduced itching up to 24 hours after dosing to treat allergic conjunctivitis, according to a study.Using the conjunctival allergen challenge (CAC) model, the double-masked phase 3 clinical trial randomized 345 patients 2:2:2:1 to receive olopatadine 0.77%, olopatadine 0.2%, olopatadine 0.1% or vehicle, respectively.